intermittent claudication
Pentoxifylline for intermittent claudication
... A systematic review published in 2012 compared pentoxifylline, cilostazol and naftidrofuryl oxalate versus placebo, or versus one another, for the treatment of intermittent claudication in individ- uals ...
70
Feasibility study to evaluate cycloidal vibration therapy for the symptomatic treatment of intermittent claudication
... Thirty-four participants were recruited from a single ter- tiary vascular unit within Mid Yorkshire NHS Trust, United Kingdom, over a period of 14 months between July 2014 and September 2015. Inclusion criteria were (1) ...
11
Influence of regular exercise on body fat and eating patterns of patients with intermittent claudication
... Absolute or relative % change in walking ability, anthropometric measures and body fat of healthy adults Control and age- matched patients with intermittent claudication undertaking 3 an[r] ...
16
Comparison of upper limb and lower limb exercise training in patients with intermittent claudication
... suggested, intermittent claudication typically affects the physical functioning domains of the SF-36 questionnaire, and it is therefore not surprising that no significant differences were observed either ...
323
Abdominal aortic aneurysm in patients affected by intermittent claudication: prevalence and clinical predictors
... with intermittent claudication seems to be the same than in general ...with intermittent claudi- cation, and that the neutrophil count did not correlate with ...with intermittent ...
5
Optimization, ex vivo permeation, and stability study of lipid nanocarrier loaded gelatin capsules for treatment of intermittent claudication
... Abstract: In this study, an optimized nanodispersible oral dosage form (containing a lactate ester) was developed for cilostazol (CZL). CZL is a phosphodiesterase inhibitor used for intermittent ...
20
The progression rate of peripheral arterial disease in patients with intermittent claudication: a systematic review
... Currently there are no predictive formulae that allow the clinician to estimate the level of risk of an individual patient with intermittent claudication to progress to crit- ical limb ischaemia or the time ...
9
Change in dietary intake of adults with intermittent claudication undergoing a supervised exercise program and compared to matched controls
... and intermittent claudication prior to commencing 12 weeks supervised exercise training (SET) and n (%) meeting Australian recommendations a in comparison with gender, age (±5 years) and weight (±5 kg) ...
7
Endovascular treatment of lower extremity arteries is associated with an improved outcome in diabetic patients affected by intermittent claudication
... of intermittent claudication varies depending on the sever- ity of walking impairment and the associated impact of this functional disability on individual lifestyle ...and intermittent ...
5
A Case of Polyarteritis Nodosa Presenting as Rapidly Progressing Intermittent Claudication of Right Leg
... Peripheral vascular disease is not an uncommon finding in the general population. Usually it is slowly progressive associ- ated with risk factors such as smoking, diabetes mellitus, and dyslipidaemia. They commonly ...
5
Haemostasis, inflammation and renal function following exercise in patients with intermittent claudication on statin and aspirin therapy
... and intermittent claudication (IC) ...with intermittent claudication may induce a systemic thrombo-inflammatory response ...with intermittent claudication ...
8
Application of adaptive design and decision making to a phase II trial of a phosphodiesterase inhibitor for the treatment of intermittent claudication
... stable intermittent claudication for recruitment, an adaptive approach was used to rapidly identify and restrict randomization to the maximum safe and well- tolerated doses of K-134 in the target population ...
9
Influence of regular exercise on body fat and eating patterns of patients with intermittent claudication
... Absolute or relative % change in walking ability, anthropometric measures and body fat of healthy adults Control and age- matched patients with intermittent claudication undertaking 3 an[r] ...
17
Diabetes mellitus and intermittent claudication: a cross-sectional study of 920 claudicants
... The IC diagnosis was ensured by medical history (in- cluding Edinburgh questionnaire), physical exploration and Ankle-brachial Index [3]. All included patients gave their informed consent to enter the study. Criteria for ...
8
Efficacy and Feasibility of Pain management and Patient Education for Physical Activity in Intermittent claudication (PrEPAID): protocol for a randomised controlled trial
... Peripheral arterial disease (PAD) affects 2.7 million people in the UK [1]. The most common symptom that patients experience is intermittent claudication (IC), which is pain in the buttock, calf or thigh ...
12
Activation of neutrophils, platelets and the coagulation system in intermittent claudication
... of intermittent claudication, and that the odds ratio remained significant even after adjustment for other cardiovascular risk ...and claudication, but only the association with peripheral arterial ...
259
Exercise for intermittent claudication
... their claudication; however, this is only one aspect of a progressive debilitating disease that can lead to limb loss and is accompanied by the coexistent risk of cardiovascular ...
106
Preferred exercise modalities in patients with intermittent claudication
... It is estimated that 5% of the population over the age of 50 will suffer with ischaemic muscle pain during exercise due to intermittent claudication (IC), a symptom of peripheral arterial disease (PAD) (1). ...
16
Review of the adaptation of skeletal muscle in intermittent claudication
... of intermittent claudication (IC) on mobility, balance and quality of life; the underlying pathophysiology and alterations in muscle architecture secondary to the disease are often ...exercise, ...
14
Extracorporeal shockwave therapy for the treatment of lower limb intermittent claudication: study protocol for a randomised controlled trial (the SHOCKWAVE 1 trial)
... [1]. Intermittent claudication (IC), a manifestation of PAD in the lower limbs, causes sufferers to experience cramping pain in the affected muscles, most commonly the calves, which occurs after walking a ...
11